Cardiol Therapeutics Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Emerging growth company
State of Incorporation
Ontario, Canada
Business Address
602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE, A6, L6H 0G5
Mailing Address
602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE, A6, L6H 0G5
Phone
289-910-0850
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | April 1, 2026 | View on SEC |
| 40-F Canadian company annual report | March 31, 2026 | View on SEC |
| 6-K Foreign company current report | February 25, 2026 | View on SEC |
| 6-K Foreign company current report | February 10, 2026 | View on SEC |
| 6-K Foreign company current report | February 2, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 30, 2026 | View on SEC |
| 6-K Foreign company current report | January 26, 2026 | View on SEC |
| 6-K Foreign company current report | January 23, 2026 | View on SEC |
| 6-K Foreign company current report | January 16, 2026 | View on SEC |
| 6-K Foreign company current report | January 13, 2026 | View on SEC |
Annual Reports
40-F
March 31, 2026
- Lead drug candidate CardiolRx™ targets heart inflammation and scarring
- Strong cash position of $48.5 million to fund ongoing clinical trials
Related Companies
Companies in the same industry (SIC: 2836)
Scinai Immunotherapeutics Ltd.
SCNI
Biological Products, (No Diagnostic Substances)
Genenta Science S.p.A.
GNTA
Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd
GRML
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Innate Pharma SA
IPHA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.